4.7 Review

Updates in Endoscopic Bariatric and Metabolic Therapies

Related references

Note: Only part of the references are listed.
Article Surgery

The Efficacy Comparison of Endoscopic Bariatric Therapies: 6-Month Versus 12-Month Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty

K. Kozlowska-Petriczko et al.

Summary: This study compared the effects of 6-month intragastric balloon (IGB) therapy, 12-month IGB therapy, and endoscopic sleeve gastroplasty (ESG). The results showed that ESG was a more effective obesity treatment modality than IGB.

OBESITY SURGERY (2023)

Article Endocrinology & Metabolism

Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes

Suzanne Meiring et al.

Summary: DMR with GLP-1 can improve glycemic and metabolic control in patients with T2DM by modulating postprandial bile acid responses, including increased unconjugated and secondary bile acids.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2022)

Review Gastroenterology & Hepatology

Siddharth Singh, Section Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta

Pichamol Jirapinyo et al.

Summary: This study assessed the effectiveness of endoscopic bariatric and metabolic therapies (EBMTs) for the treatment of nonalcoholic fatty liver disease (NAFLD). The findings showed that EBMTs can significantly reduce liver fibrosis and improve other NAFLD-related outcomes and metabolic parameters. However, the quality of evidence for the primary outcomes was low.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Surgery

Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis

Shailendra Singh et al.

Summary: Primary Obesity Surgery Endoluminal (POSE) is a safe and effective minimally invasive endoscopic bariatric therapy that meets and exceeds the ASGE joint task force thresholds for obesity treatment outcomes. Future studies should focus on evaluating newer versions of the procedure that emphasize gastric body plication while sparing the fundus.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)

Editorial Material Medicine, General & Internal

Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?

Christopher E. Brightling et al.

LANCET (2022)

Review Endocrinology & Metabolism

Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis

Mengting Ren et al.

Summary: This study evaluated the effects of endoscopic bariatric and metabolic therapies (EBMTs) on non-alcoholic fatty liver disease (NAFLD) in patients with obesity. The results showed that EBMTs can improve liver steatosis, liver function, and insulin resistance. Further large-scale, long-term studies are needed to clarify the role of EBMTs in different stages of NAFLD.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarrier in 90 consecutively treated patients

Robert E. J. Ryder et al.

Summary: This study aimed to evaluate the safety and effectiveness of EndoBarrier in patients with suboptimally-controlled diabesity. The results showed that EndoBarrier implantation significantly improved glycemic control, weight, and related metabolic markers. Most patients maintained significant improvement even after the removal of EndoBarrier.

PRACTICAL DIABETES (2022)

Article Gastroenterology & Hepatology

Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis

Fateh Bazerbachi et al.

Summary: In a prospective study, the intragastric balloon (IGB) facilitated significant metabolic and histologic improvements in patients with NASH. The treatment appears to be safe and effective for NASH management when combined with a prescribed diet and exercise program.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty

Kaveh Hajifathalian et al.

Summary: The study suggests a significant and sustained improvement in estimated hepatic steatosis and fibrosis after Endoscopic Sleeve Gastroplasty (ESG) in patients with Nonalcoholic Fatty Liver Disease (NAFLD). Importantly, an early and weight-independent improvement in insulin resistance was shown and lasted for 2 years after the procedure.

GASTROINTESTINAL ENDOSCOPY (2021)

Review Surgery

Differences in the effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass on gut hormones: systematic and meta-analysis

Lihu Gu et al.

Summary: LSG and LRYGB procedures have different effects on gut hormones, with significant decreases in ghrelin after LSG and increases in PYY after LRYGB. However, the effects of postoperative gut hormone changes on patients are complex and should be interpreted with caution.

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Article Medicine, General & Internal

Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial

Barham K. Abu Dayyeh et al.

Summary: The study on obese adults showed that using an adjustable intragastric balloon combined with lifestyle intervention can significantly reduce weight and maintain it for 6 months. Adjusting the balloon volume allows for personalized therapy, maximizing weight loss and tolerance.

LANCET (2021)

Article Medicine, Research & Experimental

Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)

Lucia Lavin-Alconero et al.

Summary: NASH is a liver disease closely associated with obesity, and standard treatment involves diet and exercise, but with limited success. LSG is an effective weight loss surgery, but comes with postoperative complications, while endoscopic bariatric techniques offer less invasive and cost-effective obesity treatment options.

TRIALS (2021)

Review Gastroenterology & Hepatology

AGA Technical Review on Intragastric Balloons in the Management of Obesity

Raj Shah et al.

Summary: Various strategies are available to address the obesity epidemic, with endoscopic bariatric techniques such as intragastric balloons becoming an attractive alternative. This technical review includes multiple systematic reviews to support the role of intragastric balloons as a tool for weight loss, targeting clinical questions about effectiveness and periprocedural care.

GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

Association of body mass index with health care expenditures in the United States by age and sex

Zachary J. Ward et al.

Summary: This study estimated health care expenditures associated with excess weight, finding a J-shaped curve of costs by BMI, with significant increases in medical expenses for obesity and severe obesity. The findings emphasize the importance of promoting a healthy weight and preventing extreme weight gain to reduce healthcare costs across a broad range of ages and BMI levels.

PLOS ONE (2021)

Article Gastroenterology & Hepatology

Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity

Nitin Jagtap et al.

Summary: Endoscopic sleeve gastroplasty (ESG) shows significant improvement in hepatic parameters, substantial weight loss, and stable glycated hemoglobin levels in patients with NAFLD. It is a safe and effective treatment option that warrants further rigorous randomized trials for incorporation into the NAFLD treatment algorithm.

INDIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial

Vincent Huberty et al.

Summary: This study demonstrates that E-ESG is safe and effective, providing a 25% better EWL at 6 months than lifestyle modification alone. This weight loss was maintained and resulted in a significant improvement in quality of life up to 18 months after treatment.
Editorial Material Gastroenterology & Hepatology

Are We Moving in the Right Direction by Altering Gastric Motility for Weight Loss?

Reem Z. Sharaiha et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Surgery

Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis

Peiwen Li et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)

Article Gastroenterology & Hepatology

Perspectives toward minimizing the adverse events of endoscopic sleeve gastroplasty

Diogo Turiani Hourneaux de Moura et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Review Gastroenterology & Hepatology

Effect of Aspiration Therapy on Obesity-Related Comorbidities: Systematic Review and Meta-Analysis

Pichamol Jirapinyo et al.

CLINICAL ENDOSCOPY (2020)

Article Gastroenterology & Hepatology

Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study

Lea Fayad et al.

GASTROINTESTINAL ENDOSCOPY (2019)

Article Surgery

Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial

Christopher C. Thompson et al.

SURGERY FOR OBESITY AND RELATED DISEASES (2019)

Article Gastroenterology & Hepatology

Intragastric balloon treatment of obesity: Long-term results and patient satisfaction

Aline El Haddad et al.

TURKISH JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients

Aayed Alqahtani et al.

GASTROINTESTINAL ENDOSCOPY (2019)

Article Gastroenterology & Hepatology

Gastric mucosal devitalization improves blood pressure, renin and cardiovascular lipid deposition in a rat model of obesity

Andreas Oberbach et al.

ENDOSCOPY INTERNATIONAL OPEN (2019)

Article Gastroenterology & Hepatology

Gastric mucosal devitalization (GMD): translation to a novel endoscopic metabolic therapy

Lea Fayad et al.

ENDOSCOPY INTERNATIONAL OPEN (2019)

Article Gastroenterology & Hepatology

Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, and Laparoscopic Band for Weight Loss: How Do They Compare?

Aleksey A. Novikov et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2018)

Review Gastroenterology & Hepatology

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss

Aruchuna Ruban et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)

Article Surgery

Aspiration Therapy for the Treatment of Obesity: 2-4 Year Results of the PATHWAY Multicenter Randomized Controlled Trial

Christopher C Thompson et al.

Surgery for Obesity and Related Diseases (2018)

Article Gastroenterology & Hepatology

Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

Christopher C. Thompson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals

Barham K. Abu Dayyeh et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis

Violeta B. Popov et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Review Public, Environmental & Occupational Health

The Response of the US Centers for Disease Control and Prevention to the Obesity Epidemic

William H. Dietz

ANNUAL REVIEW OF PUBLIC HEALTH, VOL 36 (2015)

Article Gastroenterology & Hepatology

Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years

S. Negrin Dastis et al.

ENDOSCOPY (2009)